Spotlight
Clinical
Events
CME
Partners
Subscribe
- COVID-19
- Biosimilars
- Cataract Therapeutics
- DME
- Gene Therapy
- Workplace
- Ptosis
- Optic Relief
- Imaging
- Geographic Atrophy
- AMD
- Presbyopia
- Ocular Surface Disease
- Practice Management
- Pediatrics
- Surgery
- Therapeutics
- Optometry
- Retina
- Cataract
- Pharmacy
- IOL
- Dry Eye
- Understanding Antibiotic Resistance
- Refractive
- Cornea
- Glaucoma
- OCT
- Ocular Allergy
- Clinical Diagnosis
- Technology
Allergic response to brimonidine may remain in other forms
Albany, CA-Patients with glaucoma who have had an allergic ocular reaction to brimonidine 0.2% (Alphagan, Allergan) also experience an allergic ocular reaction to brimonidine Purite 0.15% (Alphagan P). In patients with a known allergic response to brimonidine, the likelihood of the same reaction to the reformulation is high.
Related Videos
Related Content
